
- Applied Clinical Trials-08-01-2016
- Volume 25
- Issue 8
The Pluses and Minuses of Innovation
Survey delves deep into what constitutes true game-changing innovation in clinical development.
There is hype. And there is innovation. There are expectations and reality. While the chart below is from our latest survey conducted with SCORR Marketing on innovation, this question itself doesn’t use the “i” word. Something that has the “potential to change the future of clinical trials” should be considered an innovation, but of the five choices we gave, which is a true innovation? And does it matter if it indeed changes the future?
The survey delved much deeper into what respondents think about innovation, what types of innovation is or is not being implemented, and how innovation is viewed by stakeholders. These results can be download for free
Other items of note from the survey include the majority of respondents feel that CROs are most accepting of innovative processes, while clinical sites are not; an equal number of companies have or don’t have an innovations department or infrastructure (43.4%); and the most often cited reason for hindering adoption of technological advances is cost.
Articles in this issue
about 9 years ago
Randomized Clinical Trials Face Practical and Ethical Challengesabout 9 years ago
EMA’s Future Location Remains in Doubt After Brexit Voteabout 9 years ago
Europe Tackles New Rules for Non-Clinical to Clinical Handoffabout 9 years ago
eConsent Study Provides Insights to Shape Industry Adoptionabout 9 years ago
Patient Centric MS Trial Resultsabout 9 years ago
Innovations in Patient Matchingabout 9 years ago
It’s Time to Transform Clinical Trial Operationsabout 9 years ago
Africa a Ripe Proving Ground for Digital Healthabout 9 years ago
The Data-Decision Debate: To Share or Not to Share?about 9 years ago
Phase III Trial Failures: Costly, But PreventableNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.